RAYMOND MUSCI

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Protagenic Therapeutics, Inc.\new

Filing Date Source Excerpt
2009-05-26 Raymond Musci 49 Executive Vice President, Corporate Development and Director
2010-10-25 The undersigned, a stockholder of ATRINSIC, INC., hereby nominates, constitutes and appoints Raymond Musci and Thomas Plotts, or either one of them, as proxy of the undersigned...

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-04-25